179 related articles for article (PubMed ID: 18057097)
1. Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability.
Sapey E; Bayley D; Ahmad A; Newbold P; Snell N; Stockley RA
Thorax; 2008 Jun; 63(6):493-9. PubMed ID: 18057097
[TBL] [Abstract][Full Text] [Related]
2. Repeatability of inflammatory parameters in induced sputum of COPD patients.
Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
COPD; 2007 Dec; 4(4):321-9. PubMed ID: 18027159
[TBL] [Abstract][Full Text] [Related]
3. The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data.
Basyigit I; Yildiz F; Ozkara SK; Yildirim E; Boyaci H; Ilgazli A
Ann Pharmacother; 2004 Sep; 38(9):1400-5. PubMed ID: 15252191
[TBL] [Abstract][Full Text] [Related]
4. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
[TBL] [Abstract][Full Text] [Related]
6. Variability of sputum inflammatory mediators in COPD and α1-antitrypsin deficiency.
Stone H; McNab G; Wood AM; Stockley RA; Sapey E
Eur Respir J; 2012 Sep; 40(3):561-9. PubMed ID: 22700846
[TBL] [Abstract][Full Text] [Related]
7. Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammation.
Dal Negro R; Micheletto C; Tognella S; Visconti M; Turati C
Adv Ther; 2008 Oct; 25(10):1019-30. PubMed ID: 18821068
[TBL] [Abstract][Full Text] [Related]
8. Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment.
Parnham MJ; Culić O; Eraković V; Munić V; Popović-Grle S; Barisić K; Bosnar M; Brajsa K; Cepelak I; Cuzić S; Glojnarić I; Manojlović Z; Novak-Mircetić R; Oresković K; Pavicić-Beljak V; Radosević S; Sucić M
Eur J Pharmacol; 2005 Jul; 517(1-2):132-43. PubMed ID: 15964564
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of a complementary antiinflammatory treatment with erespal in chronic obstructive and nonobstructive bronchitis].
Volkova LI; Budkova AA; Filonova NN; Khristoliubova EI; Kutuzova EB; Koroleva NV; Radzivil TT; Aminova ZR; Chuchalin AG
Ter Arkh; 2004; 76(8):51-6. PubMed ID: 15471398
[TBL] [Abstract][Full Text] [Related]
10. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers.
Mazur W; Stark H; Sovijärvi A; Myllärniemi M; Kinnula VL
Respiration; 2009; 78(2):209-16. PubMed ID: 19252398
[TBL] [Abstract][Full Text] [Related]
12. Can hypertonic saline inhalation influence preformed chemokine and mediator release in induced sputum of chronic obstructive pulmonary disease patients? Comparison with isotonic saline.
Cianchetti S; Bacci E; Bartoli ML; Ruocco L; Pavia T; Dente FL; Di Franco A; Vagaggini B; Paggiaro P
Clin Exp Allergy; 2007 Dec; 37(12):1819-26. PubMed ID: 17941910
[TBL] [Abstract][Full Text] [Related]
13. Effect of the oral leukotriene B4 receptor antagonist LTB019 on inflammatory sputum markers in patients with chronic obstructive pulmonary disease.
Grönke L; Beeh KM; Cameron R; Kornmann O; Beier J; Shaw M; Holz O; Buhl R; Magnussen H; Jörres RA
Pulm Pharmacol Ther; 2008; 21(2):409-17. PubMed ID: 18063399
[TBL] [Abstract][Full Text] [Related]
14. Clara cell 16 protein in COPD sputum: a marker of small airways damage?
Braido F; Riccio AM; Guerra L; Gamalero C; Zolezzi A; Tarantini F; De Giovanni B; Folli C; Descalzi D; Canonica GW
Respir Med; 2007 Oct; 101(10):2119-24. PubMed ID: 17624750
[TBL] [Abstract][Full Text] [Related]
15. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
16. Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies.
Snoeck-Stroband JB; Lapperre TS; Gosman MM; Boezen HM; Timens W; ten Hacken NH; Sont JK; Sterk PJ; Hiemstra PS;
Eur Respir J; 2008 Jan; 31(1):70-7. PubMed ID: 17804442
[TBL] [Abstract][Full Text] [Related]
17. 3-Chlorotyrosine in sputum of COPD patients: relationship with airway inflammation.
O'Donnell C; Newbold P; White P; Thong B; Stone H; Stockley RA
COPD; 2010 Dec; 7(6):411-7. PubMed ID: 21166629
[TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of beta(2)-adrenoreceptor in inflammatory cells of patients with chronic obstructive pulmonary disease].
Zhu WJ; He B; Xu M
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2099-102. PubMed ID: 19080468
[TBL] [Abstract][Full Text] [Related]
19. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis.
Hill AT; Campbell EJ; Hill SL; Bayley DL; Stockley RA
Am J Med; 2000 Sep; 109(4):288-95. PubMed ID: 10996579
[TBL] [Abstract][Full Text] [Related]
20. Sputum eosinophilia in idiopathic pulmonary fibrosis.
Birring SS; Parker D; McKenna S; Hargadon B; Brightling CE; Pavord ID; Bradding P
Inflamm Res; 2005 Feb; 54(2):51-6. PubMed ID: 15750711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
